Whale Analyzer
SEC 13F · Available

HHLR Advisors 13F Holdings

HHLR Advisors. China's top PE/VC investor. Zhang Lei is the founder of Hillhouse Capital, known for his early and massive investments in Tencent and JD.com. He advocates for long-term 'be a friend of time' value investing in Asia.

As of the latest Q1 2026 filing, HHLR Advisors (managing HHLR Advisors) reported a public portfolio value of $1.7B with 38 positions. The top recent buy was MRVL. The top recent sell was PDD.

Open interactive portfolio
$1.7BPortfolio value
38Holdings
Q1 2026Latest quarter
2026-05-15Filing date

HHLR Advisors 13F portfolio overview

HHLR Advisors's Q1 2026 13F holdings show HHLR Advisors reporting 38 positions with a disclosed portfolio value of $1.7B. For readers searching HHLR Advisors 13F holdings, HHLR Advisors portfolio, or HHLR Advisors holdings, the latest top holdings include PDD, Alibaba, BEONE MEDICINES, FUTU HLDGS, and LEGEND BIOTECH.

The three largest reported positions add up to roughly 62.2%, which helps readers judge portfolio concentration rather than just headline AUM. The largest reported sector exposure is Consumer Discretionary at 43.8% of the disclosed portfolio. This makes the page useful for comparing the manager's actual disclosed exposure with market narratives around the same names.

The latest change data highlights reported buys such as MARVELL TECHNOLOGY, TSMC, VIPSHOP HLDGS, INTEL, and NVIDIA and reported reductions or exits such as PDD, Alibaba, FUTU HLDGS, MAZE THERAPEUTICS, and WEBULL. Those changes should be read as historical disclosure signals, not as real-time trade alerts.

The filing metadata lists report date 2026-03-31, filing date 2026-05-15, SEC accession 0000919574-26-003551. SEC 13F reports are normally published up to 45 days after quarter end, so the data is best used to understand institutional positioning after the fact rather than to infer today's exact portfolio.

Top reported holdings

HoldingReported valueWeightQuarter change
PDD whale holders
PDD HOLDINGS INC
$425.6M25.4%Reduced
BABA whale holders
ALIBABA GROUP HLDG LTD
$307.8M18.4%Reduced
BEIGF whale holders
BEONE MEDICINES LTD
$307.2M18.4%Held
FUTU whale holders
FUTU HLDGS LTD
$194.1M11.6%Reduced
LEGN whale holders
LEGEND BIOTECH CORP
$108.3M6.5%Held
AVBP whale holders
ARRIVENT BIOPHARMA INC
$90.6M5.4%Held
BEKE whale holders
KE HLDGS INC
$63.4M3.8%Held
CWAN whale holders
CLEARWATER ANALYTICS HLDGS I
$32.3M1.9%Held
CTKB whale holders
CYTEK BIOSCIENCES INC
$29.1M1.7%Held
MRVL whale holders
MARVELL TECHNOLOGY INC
$16.9M1.0%New

Top buys

Top sells

Allocation

  • Consumer Discretionary: 43.8%
  • Health Care: 31.4%
  • Other: 21.4%
  • Information Technology: 2.1%
  • Industrials: 1.1%
  • Materials: 0.1%

Data notes

Report date: 2026-03-31

Disclosure source: SEC 13F

13F filings are delayed public disclosures and do not include every asset class, short positions, or real-time trades.

This page is generated from public filings and public disclosures. It is for research and education only and is not investment advice.

Related investor portfolios

Learn more in Whale Analyzer Academy

Frequently asked questions

What is HHLR Advisors buying?

The latest tracked change data for HHLR Advisors highlights reported buys such as MARVELL TECHNOLOGY, TSMC, VIPSHOP HLDGS, and INTEL. Because 13F data is historical, use it as a research trail rather than a live trade alert.

HHLR Advisors 13F portfolio

The Q1 2026 SEC 13F profile for HHLR Advisors and HHLR Advisors shows 38 reported positions, $1.7B in disclosed portfolio value, and top holdings including PDD, Alibaba, BEONE MEDICINES, FUTU HLDGS, and LEGEND BIOTECH.

HHLR Advisors holdings

HHLR Advisors holdings are summarized from public disclosures with reported values, weights, top buys, top sells, and filing metadata where available.

How delayed is HHLR Advisors's 13F data?

SEC Form 13F requires institutional investment managers with $100M+ in US equities to disclose their holdings quarterly. Read our comprehensive 13F guide.